131 related articles for article (PubMed ID: 38456718)
1. Serum circRNA (Circ)_0051386 assists in the diagnosis of acute ST-segment elevation myocardial infarction and prediction of the occurrence of major adverse cardiovascular events after percutaneous coronary intervention.
Xu J; Wang Z; Ai Y; Wen Y
Acta Cardiol; 2024 Apr; 79(2):215-223. PubMed ID: 38456718
[TBL] [Abstract][Full Text] [Related]
2. Preoperative lymphocyte to C-reactive protein ratio: A new prognostic indicator of post-primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Liu Y; Ye T; Chen L; Xu B; Wu G; Zong G
Int Immunopharmacol; 2023 Jan; 114():109594. PubMed ID: 36525793
[TBL] [Abstract][Full Text] [Related]
3. The value of D-dimer to lymphocyte ratio in predicting clinical outcomes after percutaneous coronary intervention in ST-segment elevation myocardial infarction patients: A retrospective study.
Cao S; Liu Y; Ye J; Wang Y; Wang Z; Li C; Jin T; Wu J; Zong G
Int Immunopharmacol; 2024 Feb; 128():111556. PubMed ID: 38241843
[TBL] [Abstract][Full Text] [Related]
4. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system.
Huang L; Zhang J; Huang Q; Cui R; Chen J
BMC Cardiovasc Disord; 2023 Apr; 23(1):198. PubMed ID: 37069503
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of gut microbiota-derived metabolites in patients with ST-segment elevation myocardial infarction.
Zhao S; Tian Y; Wang S; Yang F; Xu J; Qin Z; Liu X; Cao M; Zhao P; Zhang G; Wang Z; Zhang Y; Wang Y; Lin K; Fang S; Wang Z; Han T; Tian M; Yin H; Tian J; Yu B
Am J Clin Nutr; 2023 Mar; 117(3):499-508. PubMed ID: 36811471
[TBL] [Abstract][Full Text] [Related]
6. Prediction of microvascular obstruction by coronary artery angiography score after acute ST-segment elevation myocardial infarction: a single-center retrospective observational study.
Li Z; Yin H; Wang D; Zhang Y; Feng Y; Zhou Y; Zhou Y
BMC Cardiovasc Disord; 2022 Sep; 22(1):410. PubMed ID: 36104684
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].
Ji C; Song F; Huang X; Qu X; Qiu N; Zhu J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):299-304. PubMed ID: 36916344
[TBL] [Abstract][Full Text] [Related]
8. Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
Fang C; Chen Z; Zhang J; Jin X; Yang M
Front Cardiovasc Med; 2022; 9():1050785. PubMed ID: 36620648
[TBL] [Abstract][Full Text] [Related]
9. Significance of Multiple Lymphocyte-to-C-Reactive Protein Ratios in Predicting Long-Term Major Cardiovascular Adverse Events in Emergency Percutaneous Coronary Intervention Patients with ST-Segment Elevation Myocardial Infarction.
Ye J; Xu D; Yuan R; Cao S; Wang Z; Wang Y; Li C; Zong G
J Inflamm Res; 2024; 17():3407-3418. PubMed ID: 38828050
[TBL] [Abstract][Full Text] [Related]
10. Tpeak-Tend/QT interval predicts ST-segment resolution and major adverse cardiac events in acute ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention.
Wang X; Zhang L; Gao C; Zhu J; Yang X
Medicine (Baltimore); 2018 Oct; 97(43):e12943. PubMed ID: 30412109
[TBL] [Abstract][Full Text] [Related]
11. The role of late reperfusion in ST-segment elevation myocardial infarction: a real-world retrospective cohort study.
Guo Q; Huang J; Shen Y; Tong G; Li H; Meng S
BMC Cardiovasc Disord; 2020 Apr; 20(1):207. PubMed ID: 32345243
[TBL] [Abstract][Full Text] [Related]
12. One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention.
Liu HW; Han YL; Jin QM; Wang XZ; Ma YY; Wang G; Wang B; Xu K; Li Y; Chen SL
Chin Med J (Engl); 2018 Jun; 131(12):1412-1419. PubMed ID: 29893357
[TBL] [Abstract][Full Text] [Related]
13. The diagonal branches and outcomes in patients with anterior ST- elevation myocardial infarction.
Zhang S; Deng X; Yang W; Xia L; Yao K; Lu H; Ge L; Shen L; Sun A; Zou Y; Qian J; Ge J
BMC Cardiovasc Disord; 2020 Mar; 20(1):108. PubMed ID: 32131738
[TBL] [Abstract][Full Text] [Related]
14. Sex-Related Differences in Short- and Long-Term Outcome among Young and Middle-Aged Patients for ST-Segment Elevation Myocardial Infarction Underwent Percutaneous Coronary Intervention.
Fu WX; Zhou TN; Wang XZ; Zhang L; Jing QM; Han YL
Chin Med J (Engl); 2018 Jun; 131(12):1420-1429. PubMed ID: 29893358
[TBL] [Abstract][Full Text] [Related]
15. Positive association between stress hyperglycemia ratio and pulmonary infection in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Lin Z; Liang X; Zhang Y; Dai Y; Zeng L; Chen W; Kong S; He P; Duan C; Liu Y
Cardiovasc Diabetol; 2023 Mar; 22(1):76. PubMed ID: 37004002
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of platelet/lymphocyte ratio and CAMI-STEMI score for major adverse cardiac events in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A prospective observational study.
Wang Y; Peng Z
Medicine (Baltimore); 2021 Aug; 100(33):e26942. PubMed ID: 34414954
[TBL] [Abstract][Full Text] [Related]
17. Impact of glycemic gap on 30-day adverse outcomes in patients with acute ST-segment elevation myocardial infarction.
Wu S; Yang YM; Zhu J; Xu W; Wang LL; Lyu SQ; Wang J; Shao XH; Zhang H
Atherosclerosis; 2022 Nov; 360():34-41. PubMed ID: 36265428
[TBL] [Abstract][Full Text] [Related]
18. Predictive values of bilirubin for in-hospital adverse events in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
Ying C; Liu CF; Guo DQ; Du ZR; Wei YJ
Clinics (Sao Paulo); 2023; 78():100306. PubMed ID: 37949037
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of combining leucocyte and platelet counts for mortality in ST-segment elevation myocardial infarction patients after percutaneous coronary intervention treatment in Chinese population: a retrospective cohort study.
Yuan T; Aisan A; Maheshati T; Tian R; Li Y; Chen Y
BMJ Open; 2023 Jul; 13(7):e060756. PubMed ID: 37463806
[TBL] [Abstract][Full Text] [Related]
20. Triglyceride to high density lipoprotein cholesterol ratio may serve as a useful predictor of major adverse coronary event in female revascularized ST-elevation myocardial infarction.
Wan GX; Xia WB; Ji LH; Qin HL; Zhang YG
Clin Chim Acta; 2018 Oct; 485():166-172. PubMed ID: 29969621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
